(ERF) Eurofins Scientific SE - Performance -9.2% in 12m
Compare ERF with Indices, Sectors and Commodities and Bonds. Who performs better in which timeframe?
Performance Rating
-21.45%
#48 in Group
Rel. Strength
36.11%
#5113 in Universe
Total Return 12m
-9.24%
#55 in Group
Total Return 5y
24.19%
#34 in Group
P/E 24.3
64th Percentile in Group
P/E Forward 11.7
44th Percentile in Group
PEG 0.58
83th Percentile in Group
FCF Yield 8.74%
84th Percentile in Group
12m Total Return: ERF (-9.2%) vs XBI (-6.5%)

5y Drawdown (Underwater) Chart

Top Performers in Biotechnology
Overall best picks of Peer Group Selected by proven GARP Predictive Metrics, sorted by Growth Rating
Symbol | 1m | 12m | 5y | P/E | P/E Forward | PEG | EPS Stability |
EPS CAGR |
---|---|---|---|---|---|---|---|---|
UTHR NASDAQ United Therapeutics |
-8.25% | 25.2% | 163% | 11.9 | 10.6 | 1.43 | 83.8% | 78.5% |
HLN NYSE Haleon |
0.89% | 22.3% | 40.6% | 24.7 | 20.3 | 1.8 | 27.1% | - |
AMGN NASDAQ Amgen |
-11.6% | 4.69% | 33.7% | 36.6 | 13.3 | 0.94 | -18.8% | -20% |
LONN SW Lonza |
-1.09% | 7.58% | 35.2% | 60.7 | 31.7 | 1.15 | 12.6% | -10.3% |
BIM PA Biomerieux |
-2.83% | 12.9% | -1.51% | 31 | 24.2 | 1.45 | -58.7% | -25.1% |
KMDA NASDAQ Kamada |
-7.32% | 33% | -9.75% | 24.3 | 22.8 | 0.91 | 47.7% | 3.93% |
ERF PA Eurofins Scientific SE |
9.29% | -9.24% | 24.2% | 24.3 | 11.7 | 0.58 | -70.8% | -17.1% |
GRFS NASDAQ Grifols |
-7.23% | 11% | -64% | 26.9 | 11 | 0.23 | -45.4% | -33.9% |
Performance Comparison: ERF vs XBI vs S&P 500
XBI (SPDR S&P Biotech ETF) is the Sector Benchmark for ERF
Total Return (including Dividends) | ERF | XBI | S&P 500 |
---|---|---|---|
1 Month | 9.29% | -10.94% | -6.73% |
3 Months | 15.50% | -14.92% | -11.93% |
12 Months | -9.24% | -6.46% | 7.24% |
5 Years | 24.19% | -19.21% | 100.61% |
Trend Score (consistency of price movement) | ERF | XBI | S&P 500 |
1 Month | 1.70% | -52.8% | -63.5% |
3 Months | -24.0% | -92.8% | -90.3% |
12 Months | -42.3% | -32.4% | 60.6% |
5 Years | -64.4% | -53.3% | 84.2% |
Relative Strength (compared with Indexes) | Rank in Peer Group | vs. XBI | vs. S&P 500 |
1 Month | #23 | 22.7% | 17.2% |
3 Month | #16 | 35.8% | 31.1% |
12 Month | #56 | -2.97% | -15.4% |
5 Years | #32 | 53.7% | -38.1% |
FAQs
Does ERF Eurofins Scientific SE outperforms the market?
No,
over the last 12 months ERF made -9.24%, while its related Sector, the SPDR S&P Biotech (XBI) made -6.46%.
Over the last 3 months ERF made 15.50%, while XBI made -14.92%.
Over the last 3 months ERF made 15.50%, while XBI made -14.92%.
Performance Comparison ERF vs Indeces and Sectors
ERF vs. Indices ERF is Over or Underperforming
Symbol | 1w | 1m | 6m | 12m | |
---|---|---|---|---|---|
US S&P 500 | SPY | 7.52% | 16.0% | 24.7% | -16.5% |
US NASDAQ 100 | QQQ | 7.04% | 16.7% | 24.6% | -16.8% |
US Dow Jones Industrial 30 | DIA | 9.55% | 16.2% | 24.1% | -13.7% |
German DAX 40 | DAX | 6.30% | 13.2% | 4.81% | -29.6% |
Shanghai Shenzhen CSI 300 | CSI 300 | 8.09% | 12.7% | 23.6% | -18.5% |
Hongkong Hang Seng | HSI | 4.85% | 13.0% | 20.2% | -26.0% |
India NIFTY 50 | INDA | 5.37% | 7.26% | 21.4% | -12.2% |
Brasil Bovespa | EWZ | 3.25% | 8.83% | 19.7% | -0.50% |
ERF vs. Sectors ERF is Over or Underperforming
Symbol | 1w | 1m | 6m | 12m | |
---|---|---|---|---|---|
Communication Services | XLC | 6.81% | 16.1% | 15.6% | -24.3% |
Consumer Discretionary | XLY | 6.08% | 16.1% | 19.4% | -20.5% |
Consumer Staples | XLP | 7.37% | 6.31% | 16.8% | -20.6% |
Energy | XLE | 7.45% | 21.8% | 26.0% | 3.46% |
Financial | XLF | 6.82% | 14.1% | 15.8% | -27.1% |
Health Care | XLV | 9.79% | 17.1% | 26.9% | -6.85% |
Industrial | XLI | 8.12% | 15.3% | 24.9% | -13.3% |
Materials | XLB | 7.78% | 15.1% | 32.0% | -3.32% |
Real Estate | XLRE | 7.75% | 12.5% | 25.1% | -24.0% |
Technology | XLK | 7.25% | 18.3% | 31.0% | -10.4% |
Utilities | XLU | 7.63% | 9.09% | 21.1% | -30.9% |
Aerospace & Defense | XAR | 8.97% | 12.5% | 15.3% | -31.1% |
Biotech | XBI | 4.10% | 20.2% | 36.1% | -2.78% |
Homebuilder | XHB | 5.99% | 17.4% | 39.5% | 1.27% |
Retail | XRT | 5.65% | 14.7% | 28.2% | -2.95% |